Essential evidence-based psychopharmacology
Author(s)
Bibliographic Information
Essential evidence-based psychopharmacology
(Cambridge medicine)
Cambridge University Press, 2012
2nd ed
- : hardback
- Other Title
-
Evidence-based phamacology
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
This volume presents up-to-date, comprehensive and high quality reviews of the psychopharmacological evidence-base for each of the major psychiatric disorders, written by expert psychopharmacologists from around the world. Building on the success of the first edition, the volume summarizes the wealth of new developments in the field and sets them within the context of day-to-day clinical practice. All chapters have been fully updated and new contributions on personality disorders and substance dependence added. Each chapter provides information about optimal first line pharmacological interventions, maintenance pharmacotherapy and the management of treatment-refractory patients. The content is organized according to the DSM-V listing of psychiatric disorders, and covers all major conditions including schizophrenia, mood disorders, anxiety disorders, eating disorders and Alzheimer's disorder. These issues lie at the heart of clinical psychopharmacology, making this book invaluable to all practising and trainee clinicians, in a mental health setting or a less specialised environment.
Table of Contents
- Preface
- Foreword
- 1. Evidence-based pharmacotherapy of attention deficit hyperactivity disorder Brigitte S. Vaughan, John S. March and Christopher J. Kratochvil
- 2. Evidence-based pharmacotherapy of schizophrenia Stefan Leucht, Stephan Heres, Werner Kissling and John M. Davis
- 3. Evidence-based pharmacotherapy of bipolar disorder Matthew J. Taylor and John R. Geddes
- 4. Evidence-based pharmacotherapy of major depressive disorder Jamie M. Dupuy, Michael J. Ostacher, Jeffrey Huffman, Roy H. Perlis and Andrew A. Nierenberg
- 5. Evidence-based pharmacotherapy of panic disorder Neeltje M. Batelaan, Anton J. L. M. Van Balkom and Dan J. Stein
- 6. Evidence-based pharmacotherapy of social anxiety disorder Carlos Blanco, Laura B. Bragdon, Franklin R. Schneier and Michael R. Liebowitz
- 7. Evidence-based pharmacotherapy of generalised anxiety disorder David S. Baldwin, Sarah Waldman and Christer Allgulander
- 8. Evidence-based pharmacotherapy of obsessive-compulsive disorder Naomi A. Fineberg, Angus Brown and Ilenia Pampaloni
- 9. Evidence-based pharmacotherapy of posttraumatic stress disorder Jonathan C. Ipser and Dan J. Stein
- 10. Evidence-based pharmacotherapy of eating disorders Martine F. Flament, Hany Bissada and Wendy Spettigue
- 11. Evidence-based pharmacotherapy of nicotine and alcohol dependence Wim van den Brink
- 12. Evidence-based pharmacotherapy of illicit substance use disorders Wim van den Brink
- 13. Evidence-based pharmacotherapy of Alzheimer's disease Darren Cotterell and Martin Brown
- 14. Evidence-based pharmacotherapy of personality disorders Luis H. Ripoll, Joseph Triebwasser and Larry J. Siever
- Index.
by "Nielsen BookData"